Travel grant 2024 Switzerland, Swiss Nordic Bio 2024 on March 7th
| Reference number | |
| Coordinator | Sortina pharma AB |
| Funding from Vinnova | SEK 14 982 |
| Project duration | March 2024 - March 2024 |
| Status | Completed |
| Venture | Global cooperation 2024 |
Important results from the project
During the intensive day at Swiss Nordic Bio-partnerevenemanget, we engaged in in-depth conversations and developed meaningful relationships with a number of potential partners and investors. By actively participating in various interactions and meetings, we created a platform to foster mutually beneficial collaborations and business relationships. Our presence during the pitch session gave us the opportunity to present our company and our visions and increase our visibility.
Expected long term effects
By participating at the Swiss Nordic Bio-event, we took a step forward in our discussions with potential partners and investors. We look forward to continuing to build on the contacts and relationships we established during the event and to exploring future opportunities for collaboration and growth.
Approach and implementation
Our participation in Swiss Nordic Bio-evenemanget was a strategic opportunity for us to engage in meaningful discussions and establish valuable relationships with potential partners and investors. By actively participating in various contexts and networking opportunities, we created a platform to promote mutually beneficial collaborations and to build credibility and trust within our industry.